Jeffrey W. Sherman

Jeffrey W. Sherman

Independent, Non-executive Board Member: Horizon Therapeutics
Jeffrey (Jeff) W. Sherman, MD, FACP, is Chief Medical Officer and Executive Vice President at Horizon Therapeutics. Jeff has more than 30 years of experience in the biopharmaceutical industry at IDM Pharma, Takeda Global Research and Development, NeoPharm, Searle/Pharmacia, and Squibb/Bristol-Myers Squibb. He served on the Board of Directors of Strongbridge Biopharma and Xeris Pharmaceuticals. Jeff now serves on the Board of Directors of Xeris Biopharma following the acquisition of Strongbridge by Xeris and also on the Board of Sorriso Pharmaceuticals and Larimar Therapeutics. In addition, he is also on the Board of Directors of the Biotechnology Innovation Organization (BIO).

Jeff received his bachelor’s degree in biology from Lake Forest College and medical degree from the Rosalind Franklin University of Medicine and Science/The Chicago Medical School. He completed an internship and residency in internal medicine at Northwestern University, where he also served as a chief medical resident. Additionally, he completed fellowship training in infectious diseases at the University of California-San Francisco (UCSF) and was a research associate at the Howard Hughes Medical Institute at UCSF in allergy and immunology. Jeff is an Adjunct Assistant Professor of Medicine at the Northwestern University Feinberg School of Medicine and a member of a number of professional societies as well as a Diplomat of the National Board of Medical Examiners and the American Board of Internal Medicine. Jeff also serves on the Rosalind Franklin University of Medicine and Science College of Pharmacy Advisory Board and the Northwestern University Feinberg School of Medicine Alumni Board.

Jeff is a past chairperson and former member of the Drug Information Association (DIA) Board of Directors. He also was chairperson of the DIA Annual Meeting, received an Outstanding Service Award, is an inaugural fellow, and had served as the DIA liaison to the FDA Clinical Trial Transformation Initiative (CTTI) Steering Committee. Jeff now serves as the Horizon representative to CTTI and in addition serves on the Board of Advisors of the Center for Information and Study on Clinical Research Participation (CISCRP). He is also a member of the Global Genes Medical and Scientific Advisory Board and involved with the National Organization for Rare Diseases (NORD). Jeff in addition co-chairs the Science Advisory Board of Cures Within Reach and is on the Boards of the Erie Family Health Foundation and the Center for Healthcare Innovation (CHI).

Committee Roles:
Member of the Compensation Committee
Member of the Nominating Governance Committee